With a legacy of over 75 years in the generic API industry, this success story belongs to one of the leading international supplier of active pharmaceutical ingredients. With the industry’s broadest portfolio of over 300 API products, this multinational employs over 5,000 professionals at over 20 sites worldwide.
The case study depicts how ATE achieved the task of treating the complex API effluent with innovative application of anaerobic-aerobic combination for one of its client’s site in central India
Challenge
While going for their new factory in Central India, the client was concerned about the treatability of the complex effluent that was expected to be generated out of this unit. Also the energy cost involved in treating the effluent was a prime concern. One of the renowned project management companies were consultants to the project.
Solution
After a series of discussions with the client and consultant, an anaerobic and aerobic combination was selected. This is considered as a first of its kind solution for pharma effluent treatment.
Result
ATE successfully designed, installed and commissioned a 250 m3/day effluent treatment plant based on anaerobic-aerobic combination.
Following are the advantages of this unique solution for pharma effluent:
- Reduces over 40 per cent COD in anaerobic stage thus reducing the power consumption for aerobic treatment.
- Improves biodegradability of COD entering aeration tank.
- Overall 90 per cent reduction in COD.
